BIO VIEW Fundamentals

BIO VIEW fundamentals help investors to digest information that contributes to BIO VIEW's financial success or failures. It also enables traders to predict the movement of BIO VIEW Stock. The fundamental analysis module provides a way to measure BIO VIEW's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIO VIEW stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

BIO VIEW EBITDA Analysis

BIO VIEW's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis

Current BIO VIEW EBITDA

    
  (785 K)  
Most of BIO VIEW's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIO VIEW is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition

According to the company disclosure, BIO VIEW reported earnings before interest,tax, depreciation and amortization of (785,000). This is 100.09% lower than that of the Healthcare sector and 100.12% lower than that of the Medical Devices industry. The ebitda for all Israel stocks is 100.02% higher than that of the company.

BIO VIEW Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BIO VIEW's current stock value. Our valuation model uses many indicators to compare BIO VIEW value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BIO VIEW competition to find correlations between indicators driving BIO VIEW's intrinsic value. More Info.
BIO VIEW is number one stock in current ratio category among related companies. It is number one stock in working capital category among related companies reporting about  8,411,215  of Working Capital per Current Ratio. . Comparative valuation analysis is a catch-all model that can be used if you cannot value BIO VIEW by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BIO VIEW's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BIO VIEW's earnings, one of the primary drivers of an investment's value.

BIO VIEW Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIO VIEW's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIO VIEW could also be used in its relative valuation, which is a method of valuing BIO VIEW by comparing valuation metrics of similar companies.
BIO VIEW is currently under evaluation in current ratio category among related companies.

BIO VIEW Fundamentals

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BIO VIEW in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BIO VIEW's short interest history, or implied volatility extrapolated from BIO VIEW options trading.

Pair Trading with BIO VIEW

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIO VIEW position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIO VIEW will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Altria could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Altria when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Altria - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Altria Group to buy it.
The correlation of Altria is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Altria moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Altria Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Altria can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for BIO VIEW Stock

When running BIO VIEW price analysis, check to measure BIO VIEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO VIEW is operating at the current time. Most of BIO VIEW's value examination focuses on studying past and present price action to predict the probability of BIO VIEW's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO VIEW's price. Additionally, you may evaluate how the addition of BIO VIEW to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go